tiprankstipranks

Jay Duker Insider Profile

4 Followers
Jay Duker, President & CEO, Director at EyePoint Pharmaceuticals, holds 178.42K shares in EyePoint Pharmaceuticals (Ticker: EYPT), holds 40.00K shares in Carisma Therapeutics (Ticker: CARM).
tipranks
Jay Duker

Jay Duker
EyePoint Pharmaceuticals (EYPT)
President & CEO, Director

Ranked #94,212 out of 108,921 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-63.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$818K
99.95%
0.05%
A breakdown of Jay Duker's holdings

Insider Roles

EyePoint Pharmaceuticals
(EYPT)
President & CEO, Director
Carisma Therapeutics
(CARM)
Director
Roles that Jay Duker holds in companies

Most Profitable Insider Trade

Stock:
EyePoint Pharmaceuticals
(EYPT)
Rating:Informative Buy
Date:Apr 03, 2019 - Apr 03, 2020
Return:-60.20%
The most profitable trade made by Jay Duker

Jay Duker's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
EyePoint Pharmaceuticals
Mar 24, 2026
President & CEO, Director
Uninformative Buy
1.01M
$817.15K
Carisma Therapeutics
Jun 24, 2022
Director
Uninformative Buy
$400.00
List of latest transactions for each holding click on a transaction to see Jay Duker's performance on stock

Jay Duker insider profile FAQ

What is the percentage of profitable transactions made by Jay Duker?
The percentage of profitable transactions made by Jay Duker is 0%.
    What is the average return per transaction made by Jay Duker?
    The average return per transaction made by Jay Duker is -63.00%.
      What stocks does Jay Duker hold?
      Jay Duker holds: EYPT, CARM stocks.
        What was Jay Duker’s latest transaction?
        Jay Duker latest transaction was an Uninformative Buy of $1.01M.
          What was Jay Duker's most profitable transaction?
          Jay Duker’s most profitable transaction was an Informative Buy of EYPT stock on April 3, 2019. The return on the trade was -60.20%.
            What is Jay Duker's role in EyePoint Pharmaceuticals?
            Jay Duker's role in EyePoint Pharmaceuticals is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.